AR081220A1 - USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY - Google Patents

USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY

Info

Publication number
AR081220A1
AR081220A1 ARP110101770A ARP110101770A AR081220A1 AR 081220 A1 AR081220 A1 AR 081220A1 AR P110101770 A ARP110101770 A AR P110101770A AR P110101770 A ARP110101770 A AR P110101770A AR 081220 A1 AR081220 A1 AR 081220A1
Authority
AR
Argentina
Prior art keywords
teriflunomide
treatment
brain atrophy
atrophy
brain
Prior art date
Application number
ARP110101770A
Other languages
Spanish (es)
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of AR081220A1 publication Critical patent/AR081220A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de teriflunomida para tratar la atrofia cerebral en un paciente que lo necesita.Use of teriflunomide to treat cerebral atrophy in a patient in need.

ARP110101770A 2010-05-26 2011-05-24 USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY AR081220A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34849410P 2010-05-26 2010-05-26
US38937510P 2010-10-04 2010-10-04
US39140010P 2010-10-08 2010-10-08

Publications (1)

Publication Number Publication Date
AR081220A1 true AR081220A1 (en) 2012-07-04

Family

ID=44211940

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101770A AR081220A1 (en) 2010-05-26 2011-05-24 USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY

Country Status (4)

Country Link
AR (1) AR081220A1 (en)
TW (1) TW201208674A (en)
UY (1) UY33411A (en)
WO (1) WO2011150014A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061062A1 (en) * 2010-10-25 2012-05-10 Sanofi-Aventis U.S. Llc Use of teriflunomide for improving motor function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Also Published As

Publication number Publication date
UY33411A (en) 2011-12-30
WO2011150014A1 (en) 2011-12-01
TW201208674A (en) 2012-03-01

Similar Documents

Publication Publication Date Title
ECSP14017269A (en) COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY
CU20120161A7 (en) 5-FLUORO-1H-SUBSTITUTED PIRAZOLOPIRIDINS
CR20160069A (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
AR089993A1 (en) PEPTIDOMIMETIC MACROCICLES
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
UY34165A (en) ? ALDH-2 HUMAN MITOCONDRIAL COMPOUNDS FOR ADDICTION TREATMENT ?.
CL2012003385A1 (en) Incontinence treatment.
BRPI1013698A2 (en) methods for treatment with the use of combination therapy
IL229474A0 (en) Cannabinoids for use in the treatment of neuropatich pain
BR112014013843A2 (en) use of devices for the treatment of neurological diseases
CR20130464A (en) ACETIL-COA CARBOXILASA REPLACED INHIBITORS
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
CO7160080A2 (en) Lipid compositions of racecadot
GT201400242A (en) "NEW COMPOUNDS OF PIRAZOL"
BR112014000634A2 (en) Methods for treating incontinence associated with sexual activity
FI20115165A0 (en) Therapeutic and diagnostic methods
CO7121334A2 (en) Vesicular formulations
BR112014000670A2 (en) use of oligosaccharide compounds for the prevention and treatment of pathological scars
ECSP17021138A (en) DIPEPTIDIL-KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND / OR PREVENTION OF FAT ACCUMULATION
AR081220A1 (en) USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY
AR082436A1 (en) USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS
IN2014KN01772A (en)
BR112014002806A2 (en) oral cosmetic use and cosmetic process to treat and / or prevent body odor
AR085305A1 (en) USE OF TERIFLUNOMIDE FOR THE TREATMENT OF COGNITIVE DETERIORATION

Legal Events

Date Code Title Description
FB Suspension of granting procedure